Ethylene

Ethylene

SCHEMBL6995835

C=C.CCOC(C)OCC.O=C1CNS(=O)(=O)c2ccc(Cl)cc21

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.41
DAPK3 O43293 1/20 0.41
MAP4K4 O95819 1/20 0.41
RET P07949 1/20 0.41
PIM1 P11309 1/20 0.41
LTK P29376 1/20 0.41
GRK5 P34947 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CDK8 P49336 1/20 0.41
PRKX P51817 1/20 0.41
LIMK1 P53667 1/20 0.41
CDK5 Q00535 1/20 0.41
ACVR1 Q04771 1/20 0.41
PTK2 Q05397 1/20 0.41
TYRO3 Q06418 1/20 0.41
PRKAA1 Q13131 1/20 0.41
DYRK1A Q13627 1/20 0.41
NTRK3 Q16288 1/20 0.41
LRRK2 Q5S007 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6995383 0.93 CHEK1 (0.35) CHEK1DAPK3MAP4K4RETPIM1
Ethylene SCHEMBL6988767 0.85 L3MBTL1 (0.39) CA2CA1GRIA2CA12CA9
Ethylene SCHEMBL6989724 0.83 CA12 (0.36) CA2CA1CA12CA9CA7
Ethylene SCHEMBL6994474 0.78 GRIA2 (0.38) CA2CA1GRIA2CA12CA9
Cyclopropane SCHEMBL6998820 0.78 KDM4E (0.36) CA2CA1CA12CA9CA7
Ethylene SCHEMBL7110313 0.78 RET (0.42) RETGRK5TYRO3DYRK1BCA2
Ethylene SCHEMBL6995455 0.73 TDP1 (0.36) POLB
Ethylene SCHEMBL6993460 0.72 KCNA5 (0.38) ALDH1A1KDM4EHPGDHSD17B10
Ethylene SCHEMBL6999382 0.69 TDP1 (0.36) GRIA2GRIA1GRIA3GRIA4
Ethylene SCHEMBL8644508 0.65 KDM4E (0.48) CA2CA1GRIA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
EP-0749967-B1 Substituted benzothiazine derivative SUNTORY LTD (JP) 2003-01-22 EP disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
US-5874429-A ANTIISCHEMIC AGENTS; CEREBROVASCULAR DISORDERS; CIRCULATORY IDSORDERS SUNTORY LIMITED (JP) 1999-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 CHEK1 2647/4885DAPK3 2992/4885MAP4K4 2219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.